cell services business with AllianceRx, the company said April 25, 2024. In this photo is a Walgreens store on April 02, 2019 in Miami, Florida. Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates new gene and cell services with existing pharmacy assets including the large specialty pharmacy and home delivery business, AllianceRx.
“With approximately $24 billion in annual enterprise specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider that offers the industry's most robust specialty capabilities not vertically aligned with a pharmacy benefit manager,” said Walgreens chief pharmacy officer, Rick Gates.the embattled drugstore chain was “exploring options including a sale of Shields Health Solutions, the specialty pharmacy business it acquired a majority of three years ago.
Meanwhile, taxpayers, government health insurers and companies are spending more on pricey specialized prescription drugs than pills and capsules that have busted budgets for drugs historically. Under the new business, Walgreens Specialty Pharmacy will include the following: a gene and cell services pharmacy and innovation center, an 18,000-square-foot facility in Pittsburgh, Pa. “with services and capabilities for these emerging therapies, including innovative solutions for managing the complexity of the supply chain, logistics and financing as well as clinical and social needs management to ensure success for patients and partners,” the company said.